Interstitial Lung Disease: Virtual Patient Cases
The American College of Chest Physicians (CHEST) has just released a set of interactive Virtual Interstitial Lung Disease (ILD) cases for CHEST’s e-Learning platform developed by Dr. James Town, clinical instructor (Pulmonary, Critical Care and Sleep Medicine) and Dr. Shirine Allam from Emory. Users navigate a patient through a virtual clinical encounter, review clinical data, radiographic and pathologic images and make clinical decisions about “Virtual Patients” presenting with various ILDs.
Each real-life case was culled from experts from around the country and concludes with important case-specific learning points. The entire learning experience is packaged with curated video lectures about ILD topics from CHEST's 2018 Annual Meeting.
Dr. Patricia Kritek has been named Senior Deputy Editor of American Thoracic Society (ATS) Scholar. ATS Scholar is an international open access online journal publishing peer-reviewed medical education manuscripts relevant to the fields of pulmonary, critical care and sleep medicine, including those related to the teaching of common clinical topics, the training of healthcare providers and educational research.
Michalsen A, LONG AC, DeKeyser Ganz F, White DB, Jensen HI, Metaxa V, Hartog CS, Latour JM, Truog RD, Kesecioglu J, Mahn AR, CURTIS JR. Interprofessional Shared Decision-Making in the ICU: A Systematic Review and Recommendations From an Expert Panel. Crit Care Med 2019. (epub ahead of print).
Drs. David Horne and Jerry Zifodya published Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults.
HORNE DJ, Kohli M, ZIFODYA JS, Schiller I, Dendukuri N, Tollefson D, Schumacher SG, Ochodo EA, Pai M, Steingart KR. Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2019. (epub ahead of print) 6:CD009593.
Chair of Medicine Scholars Awards
Dr. Pavan Bhatraju, acting instructor, is one of the Chair of Medicine Scholar awardees for 2019. He earned his MD from the University of Louisville, KY and MSc from the University of Washington. Dr. Bhatraju’s research is focused on kidney injury both in the intensive care unit and due to medications like aminoglycosides.
The Chair of Medicine Scholars Award was established in 2013 by the Department of Medicine and awarded annually to meritorious University of Washington Department of Medicine trainees to foster the transition of awardees to the roles of physician-scientist and principal investigator as young faculty members.
The Re-evaluation Of Systemic Early neuromuscular blockade (ROSE) trial presented their results at the recent American Thoracic Society meeting in Dallas, TX. The study is the first to show that reversibly paralyzing and heavily sedating hospitalized patients with severe breathing problems do not improve outcomes in most cases. Dr. Catherine Hough, professor, is one of the researchers in the ROSE trial of the PETAL (Prevention and Early Treatment of Acute Lung Injury) Network.
Dr. Catherine Hough is the senior author of 'A multicenter study of the causes and consequences of optimistic expectations about prognosis by surrogate decision-makers in ICUs.' Dr. J. Randall Curtis is also a listed author.
White DB, Carson S, Anderson W, Steingrub J, Bird G, CURTIS JR, Matthay M, Peterson M, Buddadhumaruk P, Shields AM, Ernecoff N, Shotsberger K, Weissfeld L, Chang CH, Pike F, Lo B, HOUGH CL. A Multicenter Study of the Causes and Consequences of Optimistic Expectations About Prognosis by Surrogate Decision-Makers in ICUs. Crit Care Med 2019. (epub ahead of print).
Dr. Ganesh Raghu is the senior author of Hypersensitivity Pneumonitis: Current Concepts of Pathogenesis and Potential Targets for Treatment.
Vasakova M, Selman M, Morell F, Sterclova M, Molina-Molina M, RAGHU G. Hypersensitivity Pneumonitis: Current Concepts of Pathogenesis and Potential Targets for Treatment. Am J Respir Crit Care Med 2019. (epub ahead of print).
Dr. J. Randall Curtis is the senior author of 'Pragmatic methods to avoid intensive care unit admission when it does not align with patient and family goals.' Other Pulmonary Division authors are Drs. Ann Long, Robert Lee, and Ruth Engelberg.
Khandelwal N, LONG AC, LEE RY, McDermott CL, ENGELBERG RA, CURTIS JR. Pragmatic methods to avoid intensive care unit admission when it does not align with patient and family goals. Lancet Respir Med 2019. (epub ahead of print).
Dr. Ganesh Raghu is the first author of 'Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study.' Dr. Lawrence Ho is also listed as an author.
RAGHU G, van den Blink B, Hamblin MJ, Brown AW, Golden JA, HO LA, Wijsenbeek MS, Vasakova M, Pesci A, Antin-Ozerkis DE, Meyer KC, Kreuter M, Moran D, Santin-Janin H, Aubin F, Mulder GJ, Gupta R, Richeldi L. Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study. Lancet Respir Med 2019. (epub ahead of print).
Dr. Erin Kross is the senior author of 'Aligning use of intensive care with patient values in the USA: past, present, and future.'
Turnbull AE, Bosslet GT, KROSS EK. Aligning use of intensive care with patient values in the USA: past, present, and future. Lancet Respir Med 2019. (epub ahead of print).